| | EPA Method 529 Surrogate Standard Stock SolutionCAS:4165-60-0 |
|
| | N-亚硝基正丙胺-D14CAS:93951-96-3 |
|
| | EPIDERMAL GROWTH FACTOR RECEPTORCAS:62229-50-9 |
|
| | EPIDERMAL MITOSIS INHIBITING*PENTAPEPTID ECAS:106678-69-7 |
|
| | Epi-galanthamine N-OxideCAS:366485-18-9 |
|
| | EPIDERMAL GROWTH FACTOR RECEPTOR*FRAGMEN T 1005-1016CAS:96249-43-3 |
|
| | EPICEDROL,(-)-(RG)CAS:19903-73-2 |
|
| | EPIANDROSTERONE ACETATECAS:1239-31-2 |
|
| | 氯菊酯/苄氯菊酯/3-苯氧基苄基-2,2-二甲基-3-(2,2-二氯乙烯基)-1-环丙烷羧酸酯CAS:52645-53-1 |
|
| | 7-Epi 10-Desacetyl PaclitaxelCAS:78454-17-8 |
|
| | 5-epi-IsofagomineCAS:202979-51-9 |
|
| | 4-Epi Minocycline (approximately 60% pure, contains unidentified salts)CAS:43168-51-0 |
|
| | 16-Epiestriol-d6CAS:221093-41-0 |
|
